Replies to post #296233 on NorthWest Biotherapeutics Inc (NWBO)

[Sharkee2]

Maybe true before the last few months. But the pattern has changed for the last few months, for the better.

From the 5/29 filing

The common stock is being offered in two groups: the first ($741,234) was priced at $0.17 per share through May 20, 2020 and the second ($2,541,854) was priced at $0.225 through May 28, 2020. In every case, the price per share was the then current ten day trailing average share price, which began to significantly increase on May 21, 2020. The warrants being issued with the common stock are exercisable at a weighted average exercise price of $0.23.

From the 4/9 filing

In connection with this prospectus supplement and the accompanying prospectus, Northwest Biotherapeutics, Inc. (the “Company,” “we” or “us”) is entering into financings totaling $3,801,896. The financings are comprised of $3,051,896 from the offering of common stock and warrants, and $750,000 from a convertible note. The common stock is being offered at a price of $0.153 per share, which was an above-market price during the relevant period of the negotiations.